News & Publications

rss_small RSS - Hermo Pharma News

 
  • 11.04.2014
    Loss of MANF results in diabetes in mice via an ER stress mechanism
    Read more
  • 24.01.2014
    Hermo Pharma strengthens its Board of Directors
    Read more
  • 08.11.2013
    Hermo Pharma appoints Pekka Simula as new CEO
    Read more
  • 07.10.2013
    CDNF patent granted in Canada
    Read more
  • 05.09.2013
    Topline data from amblyopia phase 2 study
    Read more
  • 28.08.2013
    Amblyopia Phase 2 topline data to be reported at the Neurotech Investment meeting in Helsinki
    Read more
  • 01.07.2013
    Hermo Pharma raises nearly 1 million in Series A second closing
    Read more
  • 16.04.2013
    Gene therapy with CDNF provides functional benefits in a rat model of Parkinson's disease
    Read more
  • 12.04.2013
    Transformative healthcare - 2013 is a big year for Hermo Pharma
    Read more
  • 15.03.2013
    Hermo Pharma a Finalist for the 2013 Red Herring Top 100 Europe Award
    Read more
  • 07.03.2013
    CDNF patent granted in Japan
    Read more
  • 09.02.2013
    Review on how antidepressants enhance neuronal plasticity
    Read more
  • 05.02.2013
    Last patients completed treatment in amblyopia phase 2a clinical study
    Read more
  • 04.02.2013
    Characterization of mammalian posttranslational modifications of GDNF
    Read more
  • 23.01.2013
    CDNF patent granted in Australia
    Read more
  • 18.01.2013
    Selection among Top 20 startup companies in Finland
    Read more
  • 14.11.2012
    Update in the R&D pipeline
    Read more
  • 14.11.2012
    Patient recruitment completed for HER-801 phase 2a clinical study
    Read more
  • 29.10.2012
    Modulation of neuronal plasticity to treat neurodevelopmental disorders in adulthood
    Read more
  • 01.10.2012
    Hermo Pharma a finalist in Rising Star Award competition
    Read more
  • 18.09.2012
    Meet us at the Biotech in Europe Investor Forum or Biopartnering FutureEUROPE
    Read more
  • 07.08.2012
    Meet us at the Nordic Congress of Ophthalmology in Helsinki
    Read more
  • 11.06.2012
    Meet us at BIO 2012 in Boston
    Read more
  • 10.06.2012
    NPAS4 gene regulates plasticity in adult visual cortex
    Read more
  • 04.05.2012
    Meet us at BioEquity Europe 2012 Frankfurt
    Read more
  • 24.04.2012
    Jonathan Knowles invests in Hermo Pharma's Series A round
    Read more
  • 13.03.2012
    US Patent Office grants a patent on amblyopia therapy to Hermo Pharma
    Read more
  • 23.02.2012
    First patients completed the amblyopia phase 2a study
    Read more
  • 02.01.2012
    Fear erasure in mice requires synergy between antidepressant drugs and extinction training
    Read more
  • 09.12.2011
    Hermo Pharma selected as one of the 30 most promising Finnish growth companies
    Read more
  • 09.11.2011
    Notice of Allowance for U.S. patent covering amblyopia treatment
    Read more
  • 03.11.2011
    License agreement on sales of recombinant CDNF protein for research use
    Read more
  • 29.09.2011
    CDNF is both neuroprotective and neurorestorative in MPTP mouse model of Parkinson's disease
    Read more
  • 20.09.2011
    Professor Barry Hoffer comments on preclinical CDNF data from rodent models of Parkinson's disease
    Read more
  • 29.08.2011
    Tekes grants Hermo Pharma funding for clinical development of Amblyopia in adults Therapy
    Read more
  • 29.08.2011
    Michael J. Fox Foundation awards additional $188,818 to professor Mart Saarma for therapeutic development for Parkinson’s disease
    Read more
  • 15.08.2011
    Sigrid Booms joins Hermo Pharma as Director of Clinical Development
    Read more
  • 24.05.2011
    Position available for Director of Clinical Development
    Read more
  • 21.04.2011
    Hermo Pharma closes first industrial partnership agreement with major pharmaceutical company
    Read more
  • 17.03.2011
    CTA approval for HER-801 phase 2a study
    Read more
  • 07.03.2011
    Meet us at BIO-Europe Spring in Milan
    Read more
  • 09.02.2011
    Tekes grants funding for preclinical development of CDNF for Parkinson's disease
    Read more
  • 31.01.2011
    Data for chronic infusion of CDNF in rat model of Parkinson's disease
    Read more
  • 27.01.2011
    Clinical Trial Application for adult amblyopia filed
    Read more
  • 10.01.2011
    Syndecan-3 identified as a novel receptor for GDNF
    Read more
  • 03.01.2011
    An epigenetic mechanism involved in adult visual cortex plasticity
    Read more
  • 16.12.2010
    Mart Saarma nominated in EMBO Council
    Read more
  • 09.12.2010
    Hermo Pharma at Bio-Europe 2010
    Read more
  • 03.12.2010
    Pekka Männistö Receives Honorary Doctorate
    Read more
  • 09.11.2010
    Jonathan Knowles receives Scrip Lifetime Achievement Award 2010
    Read more
  • 03.11.2010
    MANF has a unique mechanism to rescue apoptotic neurons
    Read more
  • 06.10.2010
    Lehdistötiedote 6.10.2010: Michael J. Fox apuraha
    Read more
  • 06.10.2010
    Michael J. Fox Foundation awards a grant to support development of CDNF
    Read more
  • 05.10.2010
    CDNF EPO patent granted to Hermo Pharma
    Read more
  • 05.10.2010
    Growth mentoring by Culminatum Innovation
    Read more
  • 11.08.2010
    Hermo Pharma acquires rights to the CDNF technology
    Read more
  • 01.04.2010
    Tekes grants Hermo Pharma funding for preclinical development of HER-801
    Read more
  • 01.03.2010
    Hermo Pharma selected in Tekes' Pharma Business and Marketing Mentoring Program
    Read more
  • 21.02.2010
    The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity
    Read more
  • 11.02.2010
    Tekes awards Hermo Pharma a grant for business development
    Read more
  • 03.01.2010
    Hermo Pharma Ltd. announces appointments for Board of Directors
    Read more
  • 20.12.2009
    Role of Brain-Derived Neurotrophic Factor in the aetiology of depression: implications for pharmacological treatment
    Read more
  • 16.12.2009
    Hermo Pharma Ltd. closes first round of financing
    Read more
  • 15.12.2009
    Executive management nominations
    Read more
  • 15.11.2009
    Physiological and pathophysiological outcomes of the interactions of HMGB1 with cell surface receptors
    Read more
  • 10.11.2009
    Novel CDNF/MANF family of neurotrophic factors (new review article)
    Read more
  • 01.11.2009
    Neural plasticity and recovery from depression
    Read more
  • 25.09.2009
    Regulation of Brain-Derived Neurotrophic Factor (BDNF) and Cerebral Dopamine Neurotrophic Factor (CDNF) by anti-Parkinsonian drug therapy in vivo
    Read more
  • 17.09.2009
    Constitutive Ret signaling is protective for dopaminergic cell bodies but not for axonal terminals
    Read more
  • 03.08.2009
    Mesencephalic astrocyte-derived neurotrophic factor is neurorestorative in rat model of Parkinson's disease
    Read more
  • 15.07.2009
    Heparin-binding determinants of GDNF reduce its tissue distribution but are beneficial for the protection of nigral dopaminergic neurons
    Read more
  • 30.06.2009
    Co-treatment with diazepam prevents the effects of fluoxetine on the proliferation and survival of hippocampal dentate granule cells
    Read more
  • 25.06.2009
    Inhibition of Acyl-coenzyme A: Cholesterol Acyl Transferase modulates amyloid precursor protein trafficking in the early secretory pathway
    Read more
  • 05.05.2009
    Tekes awards Hermo Pharma a grant for initiation of business activities
    Read more
  • 01.02.2009
    Chronic fluoxetine treatment increases expression of synaptic proteins in the hippocampus of the ovariectomized rat: role of BDNF signalling
    Read more
  • 11.01.2009
    Neuronal regulation of immune responses in the central nervous system
    Read more
  • 11.01.2009
    Novel N-terminal cleavage of APP precludes Aβ generation in ACAT-defective AC29 cells
    Read more
  • 02.01.2009
    The structure of the conserved neurotrophic factors MANF and CDNF explains why they are bifunctional
    Read more
  • 01.01.2009
    Evidence that DmMANF is an invertebrate neurotrophic factor supporting dopaminergic neurons
    Read more
  • 01.01.2009
    MANF is widely expressed in mammalian tissues and differently regulated after ischemic and epileptic insults in rodent brain
    Read more
  • 03.08.2008
    The antidepressant fluoxetine restores plasticity in the adult visual cortex
    Read more